Jos F. Brouwers

Prof. Dr. Jos F. Brouwers

Analysis Techniques in the Life Sciences, Avans University of Applied Sciences, Breda, The Netherlands
orcid

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 December 2003 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
KHKlazien Huitema
Klazien Huitema
JDJoep van Den Dikkenberg
Joep van Den Dikkenberg
JBJos F. Brouwers
Jos F. Brouwers
JHJoost Cm Holthuis
Joost Cm Holthuis
Sphingomyelin (SM) is a major component of animal plasma membranes. Its production involves the transfer of phosphocholine from phosphatidylcholine onto ceramide, yielding diacylglycerol as a side product. This reaction is catalysed by SM synthase, an enzyme whose biological potential can be judged from the roles of diacylglycerol and ceramide as anti‐ and proapoptotic stimuli, respectively. SM synthesis occurs in the lumen of the Golgi as well as on the cell surface. As no gene for SM synthase has been cloned so far, it is unclear whether different enzymes are present at these locations. Using a functional cloning strategy in yeast, we identified a novel family of integral membrane proteins exhibiting all enzymatic features previously attributed to animal SM synthase. Strikingly, human, mouse and Caenorhabditis elegans genomes each contain at least two different SM synthase (SMS) genes. Whereas human SMS1 is localised to the Golgi, SMS2 resides primarily at the plasma membrane. Collectively, these findings open up important new avenues for studying sphingolipid function in animals.

1 December 2002 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
DKDesiree van der Kleij
Desiree van der Kleij
ELEicke Latz
Eicke Latz
JBJos F. Brouwers
Jos F. Brouwers
YKYvonne C. M. Kruize
Yvonne C. M. Kruize
MSMarion Schmitz
Marion Schmitz
MYMaria Yazdanbakhsh
Maria Yazdanbakhsh
Schistosome infections are characterized by prominent T cell hyporesponsiveness during the chronic stage of infection. We found that schistosome-specific phosphatidylserine (PS) activated TLR2 and affected dendritic cells such that mature dendritic cells gained the ability to induce the development of IL-10-producing regulatory T cells. Using mass spectrometry, schistosomal lysophosphatidylserine (lyso-PS) was identified as the TLR2-activating molecule. This activity appears to be a unique property of schistosomal lyso-PS, containing specific acyl chains, because neither a synthetic lyso-PS (16:0) nor PS isolated from the mammalian host activates TLR2. Taken together, these findings provide evidence for a novel host-parasite interaction that may be central to long term survival of the parasite and limited host pathology with implications beyond parasitology.

29 May 2019 in GigaScience
Verified
Journal Article
Open access
PDF file
MMMartijn R. Molenaar
Martijn R. Molenaar
AJAike Jeucken
Aike Jeucken
TWTsjerk A Wassenaar
Tsjerk A Wassenaar
CLChris H A van de Lest
Chris H A van de Lest
JBJos F. Brouwers
Jos F. Brouwers
J.B. HelmsJ.B. Helms
J.B. Helms
Background: A major challenge for lipidomic analyses is the handling of the large amounts of data and the translation of results to interpret the involvement of lipids in biological systems. Results: We built a new lipid ontology (LION) that associates >50,000 lipid species to biophysical, chemical, and cell biological features. By making use of enrichment algorithms, we used LION to develop a web-based interface (LION/web, www.lipidontology.com) that allows identification of lipid-associated terms in lipidomes. LION/web was validated by analyzing a lipidomic dataset derived from well-characterized sub-cellular fractions of RAW 264.7 macrophages. Comparison of isolated plasma membranes with the microsomal fraction showed a significant enrichment of relevant LION-terms including “plasma membrane", “headgroup with negative charge", "glycerophosphoserines", “above average bilayer thickness", and “below average lateral diffusion". A second validation was performed by analyzing the membrane fluidity of Chinese hamster ovary cells incubated with arachidonic acid. An increase in membrane fluidity was observed both experimentally by using pyrene decanoic acid and by using LION/web, showing significant enrichment of terms associated with high membrane fluidity ("above average", "very high", and "high lateral diffusion" and "below average transition temperature"). Conclusions: The results demonstrate the functionality of LION/web, which is freely accessible in a platform-independent way.

26 May 2017 in PLOS Biology
Verified
Journal Article
Open access
PDF file
NCNutabi Camargo
Nutabi Camargo
AGAndrea Goudriaan
Andrea Goudriaan
ADAnne-Lieke F. van Deijk
Anne-Lieke F. van Deijk
WOWillem M. Otte
Willem M. Otte
JBJos F. Brouwers
Jos F. Brouwers
MVMark H G Verheijen
Mark H G Verheijen
In the vertebrate nervous system, myelination of axons for rapid impulse propagation requires the synthesis of large amounts of lipids and proteins by oligodendrocytes and Schwann cells. Myelin membranes are thought to be cell-autonomously assembled by these axon-associated glial cells. Here, we report the surprising finding that in normal brain development, a substantial fraction of the lipids incorporated into central nervous system (CNS) myelin are contributed by astrocytes. The oligodendrocyte-specific inactivation of sterol regulatory element-binding protein (SREBP) cleavage-activating protein (SCAP), an essential coactivator of the transcription factor SREBP and thus of lipid biosynthesis, resulted in significantly retarded CNS myelination; however, myelin appeared normal at 3 months of age. Importantly, embryonic deletion of the same gene in astrocytes, or in astrocytes and oligodendrocytes, caused a persistent hypomyelination, as did deletion from astrocytes during postnatal development. Moreover, when astroglial lipid synthesis was inhibited, oligodendrocytes began incorporating circulating lipids into myelin membranes. Indeed, a lipid-enriched diet was sufficient to rescue hypomyelination in these conditional mouse mutants. We conclude that lipid synthesis by oligodendrocytes is heavily supplemented by astrocytes in vivo and that horizontal lipid flux is a major feature of normal brain development and myelination. The myelin membrane is a highly specialized plasma membrane that enwraps axons, acts as an insulator, and is thus important for fast conduction of action potentials. It is thereby critical for proper functioning of the nervous system. Myelin in the central nervous system is synthesized by oligodendrocytes. Because myelin has a high lipid content, it is vulnerable to lipid metabolism disorders. It is unknown whether extracellular lipids also contribute to myelination by oligodendrocytes under healthy conditions, and if they do, what the origin of these lipids would be. Here, we show that formation of myelin membrane in mice does not only need lipid synthesis by oligodendrocytes, but also requires extracellular lipids provided by astrocytes. Indeed, when lipid synthesis was inactivated in either oligodendrocytes or astrocytes, myelin membrane synthesis was reduced. However, when lipid synthesis was inactivated in both cell types, myelin membrane synthesis was virtually absent. Furthermore, when lipid synthesis was inactivated in astrocytes, oligodendrocytes bypassed this deficiency by using dietary lipids for myelin membrane synthesis. Furthermore, a high-fat diet could promote myelin synthesis. We conclude that extracellular lipids, either provided by astrocytes or in the diet, contribute to myelination by oligodendrocytes during normal brain development.

1 March 2019 in Cell Stem Cell
Verified
Journal Article
Open access
RKRik Van Der Kant
Rik Van Der Kant
VLVanessa F. Langness
Vanessa F. Langness
CHCheryl M. Herrera
Cheryl M. Herrera
DWDaniel A. Williams
Daniel A. Williams
LFLauren K. Fong
Lauren K. Fong
LGLawrence S.B. Goldstein
Lawrence S.B. Goldstein
Genetic, epidemiologic, and biochemical evidence suggests that predisposition to Alzheimer's disease (AD) may arise from altered cholesterol metabolism, although the molecular pathways that may link cholesterol to AD phenotypes are only partially understood. Here, we perform a phenotypic screen for pTau accumulation in AD-patient iPSC-derived neurons and identify cholesteryl esters (CE), the storage product of excess cholesterol, as upstream regulators of Tau early during AD development. Using isogenic induced pluripotent stem cell (iPSC) lines carrying mutations in the cholesterol-binding domain of APP or APP null alleles, we found that while CE also regulate Aβ secretion, the effects of CE on Tau and Aβ are mediated by independent pathways. Efficacy and toxicity screening in iPSC-derived astrocytes and neurons showed that allosteric activation of CYP46A1 lowers CE specifically in neurons and is well tolerated by astrocytes. These data reveal that CE independently regulate Tau and Aβ and identify a druggable CYP46A1-CE-Tau axis in AD.

23 February 2023 in Nature Biotechnology
Verified
Journal Article
Open access
PDF file
DHDelilah Hendriks
Delilah Hendriks
JBJos F. Brouwers
Jos F. Brouwers
KHKarien Hamer
Karien Hamer
MGMaarten H. Geurts
Maarten H. Geurts
LLLéa Luciana
Léa Luciana
Hans CleversHans Clevers
Hans Clevers
The lack of registered drugs for nonalcoholic fatty liver disease (NAFLD) is partly due to the paucity of human-relevant models for target discovery and compound screening. Here we use human fetal hepatocyte organoids to model the first stage of NAFLD, steatosis, representing three different triggers: free fatty acid loading, interindividual genetic variability (PNPLA3 I148M) and monogenic lipid disorders (APOB and MTTP mutations). Screening of drug candidates revealed compounds effective at resolving steatosis. Mechanistic evaluation of effective drugs uncovered repression of de novo lipogenesis as the convergent molecular pathway. We present FatTracer, a CRISPR screening platform to identify steatosis modulators and putative targets using APOB−/− and MTTP−/− organoids. From a screen targeting 35 genes implicated in lipid metabolism and/or NAFLD risk, FADS2 (fatty acid desaturase 2) emerged as an important determinant of hepatic steatosis. Enhancement of FADS2 expression increases polyunsaturated fatty acid abundancy which, in turn, reduces de novo lipogenesis. These organoid models facilitate study of steatosis etiology and drug targets.